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Oxidative stress is represented as an imbalance between reactive oxygen species (ROS) production
and the response of antioxidant proteins. Oxidative stress is implicated in the pathogenesis of a
variety of conditions, including cardiovascular diseases, neurodegenerative diseases, and cancer.
Unfortunately, antioxidant therapies have not been proven to be effective in most clinical studies [1].
One of the reasons for this disappointing failure was testing antioxidant potential of compounds only
through their capacity to reduce the number of free radicals directly by their free radical scavenging
and metal chelating activities. It took some time to realize that some small molecules can achieve a
more significant antioxidant effect by targeted modulation of activities of proteins included in the
antioxidant system [2]. Relatively recently modulation of oxidative stress through regulation of gene
transcription has been discovered to be a promising strategy for the development of new drugs
for cardiovascular diseases and cancer types that are resistant to other treatments [3]. This Special
Issue of the “Antioxidants” collects seven original research manuscripts and six reviews addressing
different pharmacological aspects of the modulation of oxidative stress by natural and synthetic small
molecular weight compounds in regard to various therapeutic approaches in cardiovascular and
neurodegenerative diseases, cancer and diabetes. Understanding the relationship between oxidative
stress and underlying anti- and pro-oxidant mechanisms is crucial to understand mechanisms of
diseases and also for the discovery and development of innovative, targeted therapeutic strategies.
The two research articles present the results of cellular studies on contribution of antioxidants
in alleviating ischemia–reperfusion (IR) injuries in myocardial cells and cardiac fibroblasts (CF).
IR injury is a common clinical problem that occurs in the heart (in myocardial infarction) as well
as other organ systems (e.g., in the brain in stroke and in limb ischemia) and may also be a result
of reperfusion strategy or occur during surgeries [4]. IR occurs when blood supply to an organ
is diminished and then re-established. Although blood flow is necessary for survival, reperfusion
induces necrotic and apoptotic cell death. One of the key mediators of reperfusion injury is an
oxidative stress. A huge generation of ROS at the beginning of reperfusion initiates lipid peroxidation
and protein/nucleic acid oxidation, consequently activating pro-apoptotic pathways associated with
p38-MAPK and JNK proteins [5]. In their manuscript, Parra-Flores et al. [6] showed for the first time
synergistic cytoprotective effect of ascorbic acid, deferoxamine, and N-acetylcysteine in simulated
IR in CF. When added at low concentrations (10 µM) each at the onset of simulated reperfusion,
the three antioxidants synergistically reduced intracellular ROS production and increased cell viability,
induced phosphorylation of pro-survival kinases ERK1/2 (extracellular-signal-regulated kinases 1/2)
and PKB (protein kinase B)/Akt, and decreased phosphorylation of the pro-apoptotic kinases p38-MAPK
(proteins p38-mitogen-activated protein kinase) and JNK (c-Jun-N-terminal kinase). The mixture
Antioxidants 2020, 9, 657; doi:10.3390/antiox9080657 www.mdpi.com/journal/antioxidants
Antioxidants 2020, 9, 657 2 of 6
also recovered the CF function associated with wound repair by restoring serum-induced migration,
TGF-1-mediated differentiation of CF into CMF and angiotensin II-induced pro-collagen I synthesis.
The three compounds have different mechanism of antioxidant activity and act at concentrations
higher than 10 µM. However, in the mix, the oxidized form of ascorbate—dehydroascorbate, can be
transformed back in the reduced form by intracellular glutathione (GSH) [7] and the decreased
intracellular concentration of GSH may be replenished by N-acetylcysteine which is a GSH precursor.
Deferoxamine can chelate an excess of catalytic free iron which increases during ischemia and cardiac
reperfusion from cell lysis, and in this way the production of OH radicals through the Fenton reaction
is lowered, thus preventing the pro-oxidant interaction of iron with ascorbate [8]. In another study,
Peserico et al. [9] pointed to the repurposing of ezetimibe from a lipid-lowering compound to the
antioxidant with diminishing effects of the oxidative stress induced by the simulated IR in the human
monocyte-like cells THP-1 and cardiomyocytes [10]. Overnight pre-incubation of the cells with
ezetimibe (50 µM) reduced ROS formation, NF-kB activation and apoptosis, induced by simulated IR.
Ezetimibe induced up-regulation of NRF2 (Nuclear factor erythroid 2-related factor 2)/ARE (antioxidant
response element) signalling and the pro-survival UPR (unfolded protein response) pathway by
up-regulation of the pro-survival activating transcription factor 6 (ATF6) and down-regulation of
the pro-apoptotic CCAAT-enhancer-binding protein homologous protein (CHOP). In such a way,
misfolded protein mass may be reduced and cells convert to a pro-survival state. The NRF2 activation
was found to be dependent on AMPK phosphorylation.
Oxidative stress and depletion of intracellular antioxidants, together with a systemic inflammatory
response and ultimately organ failure are characteristics of the sepsis [11]. Since organ dysfunction
associated with sepsis is due, at least in part, to mitochondrial dysfunction and mitochondrial
dysfunction is considered as main cause of oxidative stress in sepsis, antioxidants targeted to
mitochondria have been considered as an efficient antioxidant protection in sepsis [12]. Minter et al. [13]
compared the positively charged antioxidant MitoVitE, which accumulates within mitochondria,
with the membrane-bound α-tocopherol and water-soluble cytosolic Trolox with regard to their effects
on oxidative stress, mitochondrial function and expression of key genes and proteins involved in the
toll-like receptor (TLR)-2 and -4 inflammatory signalling pathways in the umbilical vein endothelial
cell line HUVEC-C under conditions mimicking acute bacterial sepsis. Each of these three forms of
vitamin E (5 µM each) was found to have similar reducing effects against induced oxidative stress and
NFκB activation caused by exposure to lipopolysaccharide/peptidoglycan G. However, in difference to
α-tocopherol and Trolox, MitoVitE had also widespread downregulatory effects on gene expression
involved in TLR pathways, resulting in anti-inflammatory profile. Many of these downregulated genes
have been shown to be upregulated in mononuclear cells from patients with sepsis.
Mitochondrial dysfunction and consequential oxidative stress are also connected with organ
injuries caused by exposure to ionizing radiation in cancer therapy [14]. A serious limitation to
radiation therapy for some cancers is the possibility of irradiating the liver and induced liver injury.
When cells are exposed to radiation, the redox system begins producing free radicals a few hours after
exposure, but with the potential to last for years and cause pathological long-term persistent liver
responses to ionizing radiation, such as radiation-induced liver disease (RILD) [15]. It has been known
that major mitochondrial deacetylase sirtuin 3 (SIRT3) contributes to the development of ionizing
radiation-induced acute liver injury [16]. The results of the in vivo study conducted by LoBianco et
al. [17] show that loss of or decrease in SIRT3 levels could be an important factor contributing to a
damage-permissive phenotype in murine liver long after exposure to ionising radiation. Their study
on the two groups of Sirt3−/− and Sirt3+/+ male mice six months after their liver was exposed to 24 Gy
radiation additionally suggested that superoxide radical anion-driven acute liver injury following
radiation exposure appears to shift towards a peroxide-mediated long-term injury and is no longer
limited to the mitochondria. On the other hand, there is a possibility to use radiation to stimulate
cellular mechanisms and facilitate the removal of oxidative stress through the modulation of various
signalling pathways in the presence of nonionizing light at a specific wavelength. In their review
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article, Rajendran et al. [18] described and discussed the effects of photobiomodulation on the progress
of cancer, diabetes and wound healing through the crosstalk between ROS and the first discovered
redox-regulated transcription factor, NF-кB (nuclear factor kappa-light-chain-enhancer of activated
B cells).
A master regulator of cellular redox homeostasis is the transcription factor NRF2 [1,3]. NRF2 is a
regulator of the transactivation of over 500 cytoprotective genes, many of which are included in the
antioxidant defence against intracellular ROS increase. The major signalling pathway that regulates
oxidative stress is NRF2–KEAP1 (Kelch-like ECH-associated protein 1). Panieri et al. [19] reviewed
the activation mechanisms and the therapeutic modulation of NRF2 within the specific biological
context. In the early stages of carcinogenesis, pharmacological induction of the NRF2 pathway might
be chemopreventive. The NRF2 inducers protect normal cells from carcinogen effects by reducing
the risk of cancer initiation and development in normal cells by ROS scavenging, decreasing DNA
damage and preventing genomic instability. However, in advanced stages of cancer, the adverse effects
of the NRF2 induction might occur due to the development of therapy resistance [20]. Over-activation
of the NRF2–KEAP1 pathway in many tumours has been found to promote cancer growth and
survival, metastasis formation and therapy resistance. Sustained NRF2 activation in cancer cells lead to
metabolic changes that frequently develop “NRF2 addiction” [21]. Panieri et al. pointed to disruption
of NRF2 signalling in cancer cells by using NRF2 inhibitors as a promising therapeutic approach
against NRF2-addicted cancers.
NRF2 activators have also been proposed as antioxidants in neurodegenerative and
neuropsychiatric disorders (Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, autism,
schizophrenia, and depression) to counteract the increase in oxidative stress and inflammation.
Alvarez-Arellano et al. [22] made an overview of the role of inflammation and oxidative stress in
attention-deficit/hyperactivity disorder (ADHD). The amelioration of inflammation and oxidative stress
by natural antioxidants sulforaphane, N-acetylcysteine and omega-3 fatty acids (docosahexaenoic acid
(DHA) and eicosapentaenoic acid (EPA)) in potential adjuvant therapy of ADHD is described, and the
observed effects of these antioxidants on the activation of the NRF2 pathway in neurodegenerative
and neuropsychiatric disorders are summarized.
García-Guede et al. [23] reviewed the effects of oxidative stress on the epigenetic machinery of
DNA methylation, histone modifications and non-coding RNA, particularly microRNAs (miRNAs)
and long non-coding RNAs (lncRNAs). The influence of these epigenetic modifications is extensively
described in the case of the specific mechanisms for developing cisplatin resistance.
In the four studies reported in this Special Issue, the effects of food components on human health
through modulation of oxidative status of the body cells are investigated. One of the irreplaceable
food component necessary for maintaining health and preventing diseases for humans is ascorbic
acid/vitamin C [24]. By employing untargeted mass spectrometry and metabolomics analysis of
the C2C12 myoblast cells pre-treated with ascorbic acid (100 µM), Magaña et al. [25] suggested
that co-supplementation of ascorbate with folic acid may activate the folate-mediated one-carbon
cycle, thereby promoting the conversion of homocysteine into methionine while reducing cellular
oxidative stress. The pre-treatment of the C2C12 myoblast causes a change in the concentration
of tetrahydrofolate (THF) metabolites. Ascorbate appears to spare NAD(P)H and thus increases
availability of reducing equivalents for the reductive steps from 10-formyl-THF to 5-methyl-THF via
5,10-methylene-THF. In agreement, an increase in the levels of methionine, whose formation from
homocysteine is 5-methyl-THF dependent, and an increase in thymidine, whose formation from
deoxyuridine monophosphate (dUMP) is dependent on 5,10-methylene-THF, were observed.
Castejón et al. [26] made a comprehensive review of secoiridoid compounds of the olive
tree (Olea europaea L. (Oleaceae)) in regard to the chemical, biosynthetic and pharmacological
(including pharmacokinetic) aspects. They have tabulated and discussed the effects of the main
olive phenolics, namely, oleuropein and its aglycon, oleocanthal and oleacein, which were observed
recently in in vitro and in vivo studies in relation to the control and progression of different types of
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cancer, cardiovascular diseases and neurodegeneration processes in autoimmune diseases, as well as
their potential roles in anti-aging.
Overconsumption of some type of food has been associated with the induction of oxidative stress
and consequentially the development of pathological transformations. In the review conducted
by Cherkas et al. [27], current epidemiological evidence and redox biology advancements are
discussed with the purpose of defining the linkage between the observed disruptive metabolic effects,
detrimental health consequences of chronic nutritional carbohydrate overload and the metabolic role of
glucose in maintaining redox homeostasis. Glucose is the most important energy source and glycolysis
is a main pathway for obtaining energy when glucose is abundant and redox conditions are favourable.
The authors hypothesized that under extreme oxidative and toxic challenges, glucose provides stress
resistance by the reduction of nicotinamide adenine dinucleotide phosphate NADP+ to NADPH
through its metabolism in the pentose phosphate pathway (PPP). The reduced form NADPH is needed
for the reduction of oxidized glutathione and protein thiols, the synthesis of lipids and DNA as well as
for xenobiotic detoxification, regulatory redox signalling and counteracting infections. In regard to this
aspect, they discussed the role of glycogen stores in resistance to oxidative challenges.
The important approach to study ageing and age-linked pathologies is to investigate sex
dimorphism in the defence against metabolic stressors. In most mammals, females show lower
incidence of some age-related pathologies linked with oxidative stress conditions, and this sex
difference disappears after menopause, which led to the conclusion that this protection is attributed
to the effect of sex hormones [28]. By conducting in vivo experiments on Sirt3 wild-type (WT)
and knockout (KO) mice of both sexes fed with a standard or high-fat diet (HFD) for ten weeks,
Pinterić et al. [29] found significant sex differences in male and female mice responses at the metabolic
level, oxidant/antioxidant status, and liver mitochondrial parameters. Their study points towards a
different role of SIRT3 in males and females under the conditions of nutritive stress. For example,
the male-specific effects of an HFD include reduced SIRT3 expression in WT and alleviated lipid
accumulation and reduced glucose uptake in KO mice.
The research articles and reviews collected in this Special Issue clearly contribute to further
appreciation and enlightening of the underlying complexity of the investigation of chemical and
pharmacological aspects of modulators of oxidative stress and the importance of studying the
modulation of NRF2–KEAP1 and other relevant signalling pathways in order to develop effective
drugs for diseases in which oxidative stress plays a significant etiopathogenetic role.
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